Key Takeaways
- • Carl Icahn's firm and other hedge funds are spearheading proposed class actions challenging multibillion-dollar private equity buyouts of public companies, according to Bloomberg.
- • Glazer Capital and Empyrean Capital Partners are among the funds joining the litigation, a tool described as rarely used by hedge funds.
- • The funds are stepping into a role traditionally filled by individual shareholders and pension plans that sue after being cashed out at prices they consider too low.
- • The strategy targets buyout pricing directly, positioning activist-style investors as challengers of private equity take-private valuations.
Summary
According to Bloomberg, Carl Icahn's firm and other investors are deploying a rarely used tool for hedge funds: proposed class actions that challenge multibillion-dollar buyouts of public firms. The litigation tactic marks a shift in how hedge funds approach private equity take-privates, moving from shareholder pressure in negotiations to formal legal challenges after deals are announced.
The funds involved include Icahn's firm, Glazer Capital and Empyrean Capital Partners. Bloomberg reports that these hedge funds are seeking to fill a role traditionally played by individual shareholders and pension plans, which have historically sued after being cashed out by private equity buyers at prices they contend are too low.
The development is significant for institutional investors because it places hedge funds in an adversarial position toward private equity sponsors on pricing, and it adds litigation risk and potential cost to large take-private transactions. The source article provides limited detail on the specific deals challenged, the courts involved, or the outcomes sought, so those specifics should be confirmed against the original reporting.
The funds involved include Icahn's firm, Glazer Capital and Empyrean Capital Partners. Bloomberg reports that these hedge funds are seeking to fill a role traditionally played by individual shareholders and pension plans, which have historically sued after being cashed out by private equity buyers at prices they contend are too low.
The development is significant for institutional investors because it places hedge funds in an adversarial position toward private equity sponsors on pricing, and it adds litigation risk and potential cost to large take-private transactions. The source article provides limited detail on the specific deals challenged, the courts involved, or the outcomes sought, so those specifics should be confirmed against the original reporting.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.